You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Patients who are unfit for standard therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Elderly AML Patients, Unfit, New-diagnosis AML, Acute Myeloid Leukemia Trial in Kunming (Experimental: Venetoclax in combination

Not yet recruiting
  • Elderly AML Patients
  • +4 more
  • Experimental: Venetoclax in combination with Decitabine (+-sorafenib)
  • Active Comparator: Standard dose of Venetoclax + Azacitidine
  • Kunming, Yunnan, China
    The Second Affiliated Hospital of Kunming Medical University.
Oct 3, 2023

Multiple Myeloma Trial in Torino (Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    FO.NE.SA.Onlus
Mar 24, 2022

Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Mar 1, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Greenwich, Connecticut
  • +27 more
Dec 30, 2022

Bladder Cancer Trial in Japan (drug, procedure, radiation)

Not yet recruiting
  • Bladder Cancer
  • Kobe, Hyogo, Japan
  • +3 more
May 26, 2023

Haematological Malignancy Trial in Genève (Volumetric Arc Therapy (VMAT))

Recruiting
  • Haematological Malignancy
  • Volumetric Arc Therapy (VMAT)
  • Genève, Switzerland
    University Hospital of Geneva
May 13, 2020

Oligozoospermia, Oligoasthenozoospermia, Oligoasthenoteratozoospermia Trial in Jakarta (Electroacupuncture and Standard Therapy)

Recruiting
  • Oligozoospermia
  • +2 more
  • Electroacupuncture and Standard Therapy
  • Jakarta, Jakarta Timur, Indonesia
    Lisa Yunita
Oct 12, 2023

Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome Trial in United

Completed
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Los Angeles, California
  • +4 more
Oct 5, 2022

Squamous Cell Carcinoma of the Head and Neck Trial (Xevinapant, Placebo, cetuximab)

Not yet recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • (no location specified)
Jul 3, 2023

Gynecologic Cancer, Cancer Related Pain, Cancer Pain Trial in Jakarta (Manual Acupuncture)

Recruiting
  • Gynecologic Cancer
  • +3 more
  • Manual Acupuncture
  • Jakarta, DKI Jakarta, Indonesia
    Suryamin Hung
Oct 4, 2023

Gynecologic Cancer, Cancer Related Pain, Cancer Pain Trial in Jakarta Pusat, Jakarta (Electroacupuncture)

Recruiting
  • Gynecologic Cancer
  • +2 more
  • Electroacupuncture
  • Jakarta Pusat, DKI Jakarta, Indonesia
  • +2 more
Oct 4, 2023

Helicobacter Pylori Infection Trial in Ljubljana (Bismuth Subcitrate)

Recruiting
  • Helicobacter Pylori Infection
  • Bismuth Subcitrate
  • Ljubljana, Slovenia
    Matjaž Homan
Nov 19, 2023

Erythema, Radiation Therapy, Secondary Skin Reactions Trial in Fort Myers (VS-200Cr, Standard of care)

Not yet recruiting
  • Erythema
  • Radiation Therapy, Secondary Skin Reactions
  • VS-200Cr
  • Standard of care
  • Fort Myers, Florida
    Advocate Radiation Oncology
Aug 23, 2023

Acute Myeloid Leukemia Trial in United States (CPX-351, Venetoclax)

Completed
  • Acute Myeloid Leukemia
  • Duarte, California
  • +7 more
Nov 7, 2022

Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

Not yet recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • (no location specified)
Jun 11, 2023

Meconium Aspiration Syndrome, Surfactant Dysfunction Trial in New Delhi (Bovine surfactant)

Recruiting
  • Meconium Aspiration Syndrome
  • Surfactant Dysfunction
  • Bovine surfactant
  • New Delhi, Delhi, India
    Lady Hardinge Medical College
Oct 13, 2023

Helicobacter Pylori Infection Trial in Seoul (Tegoprazan 50 mg Triple Therapy, Tegoprazan 100 mg Triple Therapy, Lansoprazole

Recruiting
  • Helicobacter Pylori Infection
  • Tegoprazan 50 mg Triple Therapy
  • +2 more
  • Seoul, Korea, Republic of
    Chung-Ang University Hosptial
Jul 3, 2023

Acute Myeloid Leukemia in Remission Trial in Nanjing (Azacitidine, Lenalidomide)

Recruiting
  • Acute Myeloid Leukemia in Remission
  • Nanjing, Jiangsu, China
    Department of Hematology, Zhongda Hospital Southeast University,
Mar 23, 2022

Gynecologycal Cancer, Cancer Related Pain, Cancer Pain Trial in Jakarta Pusat, Jakarta (Press Needle Acupuncture)

Recruiting
  • Gynecologycal Cancer
  • +2 more
  • Press Needle Acupuncture
  • Jakarta Pusat, DKI Jakarta, Indonesia
  • +2 more
Nov 3, 2023

Severe Aplastic Anemia Trial in Tianjin (Cyclophosphamide added to standard immunosuppressive therapy with eltrombopag)

Recruiting
  • Severe Aplastic Anemia
  • Cyclophosphamide added to standard immunosuppressive therapy with eltrombopag
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Jul 27, 2023

Acute Gastroenteritis Trial (Fortified Oral Rehydration Therapy, Standard of Care Oral Rehydration Therapy)

Not yet recruiting
  • Acute Gastroenteritis
  • Fortified Oral Rehydration Therapy
  • Standard of Care Oral Rehydration Therapy
  • (no location specified)
Nov 16, 2023

Gastrointestinal Cancer Trial (Capecitabine, Sacituzumab govetican)

Not yet recruiting
  • Gastrointestinal Cancer
  • (no location specified)
Oct 2, 2023

Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Cairo (radiation, procedure, other)

Recruiting
  • Breast Cancer
  • +2 more
  • Stereotactic Ablative Radiation Therapy
  • +2 more
  • Cairo, Egypt
    National Cancer Institute
Nov 20, 2023

Advanced Solid Tumors With Neuroendocrine Differentiation Trial (surufatinib?serplulimab)

Not yet recruiting
  • Advanced Solid Tumors With Neuroendocrine Differentiation
  • (no location specified)
Nov 27, 2023

Acute Myeloid Leukemia Trial in Baltimore (Decitabine, talazoparib)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
May 31, 2022